A detailed history of Wela Strategies, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Wela Strategies, Inc. holds 2,950 shares of JNJ stock, worth $457,368. This represents 0.21% of its overall portfolio holdings.

Number of Shares
2,950
Previous 2,826 4.39%
Holding current value
$457,368
Previous $413,000 15.74%
% of portfolio
0.21%
Previous 0.19%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$145.48 - $167.38 $18,039 - $20,755
124 Added 4.39%
2,950 $478,000
Q2 2024

Jul 12, 2024

BUY
$144.38 - $157.78 $13,427 - $14,673
93 Added 3.4%
2,826 $413,000
Q1 2024

Apr 15, 2024

BUY
$155.22 - $162.74 $16,142 - $16,924
104 Added 3.96%
2,733 $432,000
Q4 2023

Jan 05, 2024

BUY
$145.6 - $158.88 $55,036 - $60,056
378 Added 16.79%
2,629 $412,000
Q3 2023

Oct 16, 2023

BUY
$155.75 - $174.48 $350,593 - $392,754
2,251 New
2,251 $350,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Wela Strategies, Inc. Portfolio

Follow Wela Strategies, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wela Strategies, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wela Strategies, Inc. with notifications on news.